eXoZymes Inc.

EXOZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.80

+$0.37 (+5.67%)

Sep 21, 2026, 12:29 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.67%

(1D)

Rating

Updated: Sep 4, 2026

20.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $63.11M

1D Range

6.27 6.93

52W Range

4.35 18.40

Valuation (TTM)

PE -5.36

PB 16.34

EV/EBITDA -5.21

Valuation (NTM)

Forward PE N/A

Forward PEG 0.88

Price Target N/A

Cash Flow

FCF Yield -12.0%

SBC Adj. FCF Yield -16.7%

SBC Impact -39.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -37.5% | N/A

FCF 3Y | 5Y -27.4% | N/A

Returns

ROA -127.7%

ROE -292.1%

ROIC -155.8%

Financial Health

Net Cash

$5.31M

Current Ratio 3.81

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The compan...

Sector Healthcare

Industry Biotechnology

Employees 32

IPO Date Nov 12, 2024

Website exozymes.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.